Pore-forming activity of BAD is regulated by specific phosphorylation and structural transitions of the C-terminal part

Biochimica et Biophysica Acta - General Subjects

Volumn 1810, Issue 2, 2011, Pages 162-169

  Polzien, Lisa ^a,f   Baljuls, Angela ^a   Roth, Heide Marie ^b   Kuper, Jochen ^b   Benz, Roland ^c   Schweimer, Kristian ^d   Hekman, Mirko ^a   Rapp, Ulf R ^a,e,f  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c JACOBS UNIVERSITY BREMEN   (Germany)

^d UNIVERSITY OF BAYREUTH   (Germany)

^e MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^f MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Bcl 2 proteins; Channel; Phosphorylation; Protein interaction; Structure

Indexed keywords

BH3 PROTEIN; LIPID BINDING DOMAIN 2 PROTEIN; LIPID BINDING PROTEIN; PROTEIN BAD; SERINE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; ARTIFICIAL MEMBRANE; BINDING AFFINITY; BINDING SITE; BIOLOGICAL MONITORING; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL DEATH; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; LIPID BILAYER; MEMBRANE MODEL; POROSITY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LIPID INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SURFACE PLASMON RESONANCE;

14-3-3 PROTEINS; AMINO ACID SEQUENCE; BCL-ASSOCIATED DEATH PROTEIN; CIRCULAR DICHROISM; GLUTATHIONE TRANSFERASE; HUMANS; LIPID BILAYERS; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SURFACE PLASMON RESONANCE; WATER;

EID: 78649789742     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2010.11.002     Document Type: Article

References (49)

1. J.C. Reed, K.S. Doctor, and A. Godzik The domains of apoptosis: a genomics perspective Sci. STKE 2004 (2004) re9.
2. N.N. Danial, and S.J. Korsmeyer Cell death: critical control points Cell 116 2004 205 219
3. C. Wang, and R.J. Youle The role of mitochondria in apoptosis* Annu. Rev. Genet. 43 2009 95 118
4. R.J. Youle, and A. Strasser The BCL-2 protein family: opposing activities that mediate cell death Nat. Rev. Mol. Cell Biol. 9 2008 47 59
5. N.N. Danial BAD: undertaker by night, candyman by day Oncogene 27 Suppl 1 2008 S53 S70
6. J.M. Adams, and S. Cory The Bcl-2 protein family: arbiters of cell survival Science 281 1998 1322 1326
7. A. Gross, J.M. McDonnell, and S.J. Korsmeyer BCL-2 family members and the mitochondria in apoptosis Genes Dev. 13 1999 1899 1911
8. S.W. Fesik Insights into programmed cell death through structural biology Cell 103 2000 273 282
9. A.M. Petros, E.T. Olejniczak, and S.W. Fesik Structural biology of the Bcl-2 family of proteins Biochim. Biophys. Acta 1644 2004 83 94
10. E. Yang, J. Zha, J. Jockel, L.H. Boise, C.B. Thompson, and S.J. Korsmeyer Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death Cell 80 1995 285 291
11. M. Hekman, S. Albert, A. Galmiche, U.E. Rennefahrt, J. Fueller, A. Fischer, D. Puehringer, S. Wiese, and U.R. Rapp Reversible membrane interaction of BAD requires two C-terminal lipid binding domains in conjunction with 14-3-3 protein binding J. Biol. Chem. 281 2006 17321 17336
12. J. Zha, H. Harada, E. Yang, J. Jockel, and S.J. Korsmeyer Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) Cell 87 1996 619 628
13. V. Ayllon, A. Fleischer, X. Cayla, A. Garcia, and A. Rebollo Segregation of Bad from lipid rafts is implicated in the induction of apoptosis J. Immunol. 168 2002 3387 3393
14. S.R. Datta, A. Katsov, L. Hu, A. Petros, S.W. Fesik, M.B. Yaffe, and M.E. Greenberg 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation Mol. Cell 6 2000 41 51
15. N. Zamzami, and G. Kroemer Apoptosis: mitochondrial membrane permeabilization-the (w)hole story? Curr. Biol. 13 2003 R71 R73
16. A. Antignani, and R.J. Youle How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr. Opin. Cell Biol. 18 2006 685 689
17. A.J. Minn, P. Velez, S.L. Schendel, H. Liang, S.W. Muchmore, S.W. Fesik, M. Fill, and C.B. Thompson Bcl-x(L) forms an ion channel in synthetic lipid membranes Nature 385 1997 353 357
18. B. Antonsson, F. Conti, A. Ciavatta, S. Montessuit, S. Lewis, I. Martinou, L. Bernasconi, A. Bernard, J.J. Mermod, G. Mazzei, K. Maundrell, F. Gambale, R. Sadoul, and J.C. Martinou Inhibition of Bax channel-forming activity by Bcl-2 Science 277 1997 370 372
19. S.L. Schendel, R. Azimov, K. Pawlowski, A. Godzik, B.L. Kagan, and J.C. Reed Ion channel activity of the BH3 only Bcl-2 family member, BID J. Biol. Chem. 274 1999 21932 21936
20. S.L. Schendel, Z. Xie, M.O. Montal, S. Matsuyama, M. Montal, and J.C. Reed Channel formation by antiapoptotic protein Bcl-2 Proc. Natl Acad. Sci. USA 94 1997 5113 5118 (Pubitemid 27214745)
21. P.H. Schlesinger, A. Gross, X.M. Yin, K. Yamamoto, M. Saito, G. Waksman, and S.J. Korsmeyer Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2 Proc. Natl Acad. Sci. USA 94 1997 11357 11362
22. T. Kuwana, M.R. Mackey, G. Perkins, M.H. Ellisman, M. Latterich, R. Schneiter, D.R. Green, and D.D. Newmeyer Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane Cell 111 2002 331 342
23. G. Basanez, A. Nechushtan, O. Drozhinin, A. Chanturiya, E. Choe, S. Tutt, K.A. Wood, Y. Hsu, J. Zimmerberg, and R.J. Youle Bax, but not Bcl-xL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations Proc. Natl Acad. Sci. USA 96 1999 5492 5497
24. L. Polzien, A. Baljuls, U.E. Rennefahrt, A. Fischer, W. Schmitz, R.P. Zahedi, A. Sickmann, R. Metz, S. Albert, R. Benz, M. Hekman, and U.R. Rapp Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation J. Biol. Chem. 284 2009 28004 28020
25. L. Polzien, R. Benz, and U.R. Rapp Can BAD pores be good? New insights from examining BAD as a target of RAF kinases Adv. Enzyme Regul. 2009
26. R. Benz, E. Maier, F.P. Thinnes, H. Gotz, and N. Hilschmann Studies on human porin. VII. The channel properties of the human B-lymphocyte membrane-derived "Porin 31HL" are similar to those of mitochondrial porins Biol. Chem. Hoppe Seyler 373 1992 295 303
27. R. Benz Permeation of hydrophilic solutes through mitochondrial outer membranes: review on mitochondrial porins Biochim. Biophys. Acta 1197 1994 167 196
28. M. del Mar Martinez-Senac, S. Corbalan-Garcia, and J.C. Gomez-Fernandez Study of the secondary structure of the C-terminal domain of the antiapoptotic protein bcl-2 and its interaction with model membranes Biochemistry 39 2000 7744 7752
29. M. del Mar Martinez-Senac, S. Corbalan-Garcia, and J.C. Gomez-Fernandez Conformation of the C-terminal domain of the pro-apoptotic protein Bax and mutants and its interaction with membranes Biochemistry 40 2001 9983 9992
30. M. Martinez-Senac Mdel, S. Corbalan-Garcia, and J.C. Gomez-Fernandez The structure of the C-terminal domain of the pro-apoptotic protein Bak and its interaction with model membranes Biophys. J. 82 2002 233 243
31. A.M. Petros, D.G. Nettesheim, Y. Wang, E.T. Olejniczak, R.P. Meadows, J. Mack, K. Swift, E.D. Matayoshi, H. Zhang, C.B. Thompson, and S.W. Fesik Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies Protein Sci. 9 2000 2528 2534
32. A. Aitken, H. Baxter, T. Dubois, S. Clokie, S. Mackie, K. Mitchell, A. Peden, and E. Zemlickova Specificity of 14-3-3 isoform dimer interactions and phosphorylation Biochem. Soc. Trans. 30 2002 351 360
33. J. Yang Molecular modeling of human BAD and its interaction with PKAc or PP1c J. Theor. Biol. 257 2009 159 169
34. M.G. Hinds, C. Smits, R. Fredericks-Short, J.M. Risk, M. Bailey, D.C. Huang, and C.L. Day Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets Cell Death Differ. 14 2007 128 136
35. S. Hiller, R.G. Garces, T.J. Malia, V.Y. Orekhov, M. Colombini, and G. Wagner Solution structure of the integral human membrane protein VDAC-1 in detergent micelles Science 321 2008 1206 1210
36. B. Leber, J. Lin, and D.W. Andrews Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes Apoptosis 12 2007 897 911
37. S.Y. Jeong, B. Gaume, Y.J. Lee, Y.T. Hsu, S.W. Ryu, S.H. Yoon, and R.J. Youle Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers EMBO J. 23 2004 2146 2155
38. M. Zoratti, and I. Szabo The mitochondrial permeability transition Biochim. Biophys. Acta 1241 1995 139 176
39. N. Zamzami, P. Marchetti, M. Castedo, T. Hirsch, S.A. Susin, B. Masse, and G. Kroemer Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis FEBS Lett. 384 1996 53 57
40. N. Zamzami, S.A. Susin, P. Marchetti, T. Hirsch, I. Gomez-Monterrey, M. Castedo, and G. Kroemer Mitochondrial control of nuclear apoptosis J. Exp. Med. 183 1996 1533 1544
41. S.S. Roy, M. Madesh, E. Davies, B. Antonsson, N. Danial, and G. Hajnoczky Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2 + -dependent cell survival and death Mol. Cell 33 2009 377 388
42. E. Gottlieb, S.M. Armour, and C.B. Thompson Mitochondrial respiratory control is lost during growth factor deprivation Proc. Natl Acad. Sci. USA 99 2002 12801 12806
43. M.G. Vander Heiden, and C.B. Thompson Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat. Cell Biol. 1 1999 E209 E216
44. E.A. Jonas, D. Hoit, J.A. Hickman, T.A. Brandt, B.M. Polster, Y. Fannjiang, E. McCarthy, M.K. Montanez, J.M. Hardwick, and L.K. Kaczmarek Modulation of synaptic transmission by the BCL-2 family protein BCL-xL J. Neurosci. 23 2003 8423 8431
45. A. Fleischer, A. Ghadiri, F. Dessauge, M. Duhamel, X. Cayla, A. Garcia, and A. Rebollo Bad-dependent rafts alteration is a consequence of an early intracellular signal triggered by interleukin-4 deprivation Mol. Cancer Res. 2 2004 674 684
46. A. Garcia, X. Cayla, A. Fleischer, J. Guergnon, F. Alvarez-Franco Canas, M.P. Rebollo, F. Roncal, and A. Rebollo Rafts: a simple way to control apoptosis by subcellular redistribution Biochimie 85 2003 727 731
47. M. Hekman, H. Hamm, A.V. Villar, B. Bader, J. Kuhlmann, J. Nickel, and U.R. Rapp Associations of B- and C-Raf with cholesterol, phosphatidylserine, and lipid second messengers: preferential binding of Raf to artificial lipid rafts J. Biol. Chem. 277 2002 24090 24102
48. K. Simons, and D. Toomre Lipid rafts and signal transduction Nat. Rev. Mol. Cell Biol. 1 2000 31 39
49. U.R. Rapp, A. Fischer, U.E. Rennefahrt, M. Hekman, and S. Albert BAD association with membranes is regulated by Raf kinases and association with 14-3-3 proteins Adv. Enzyme Regul. 47 2007 281 285